nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0717	0.126	CcSEcCtD
Mecamylamine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0551	0.0964	CcSEcCtD
Mecamylamine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0452	0.0791	CcSEcCtD
Mecamylamine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0398	0.0696	CcSEcCtD
Mecamylamine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0366	0.064	CcSEcCtD
Mecamylamine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0351	0.0613	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0337	0.0589	CcSEcCtD
Mecamylamine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0293	0.0514	CcSEcCtD
Mecamylamine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0208	0.0364	CcSEcCtD
Mecamylamine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0348	CcSEcCtD
Mecamylamine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0341	CcSEcCtD
Mecamylamine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0337	CcSEcCtD
Mecamylamine—Shock—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0312	CcSEcCtD
Mecamylamine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0302	CcSEcCtD
Mecamylamine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0285	CcSEcCtD
Mecamylamine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0276	CcSEcCtD
Mecamylamine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0273	CcSEcCtD
Mecamylamine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0271	CcSEcCtD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0133	0.0332	CbGpPWpGaD
Mecamylamine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.013	0.0227	CcSEcCtD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0123	0.0308	CbGpPWpGaD
Mecamylamine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.012	0.021	CcSEcCtD
Mecamylamine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0202	CcSEcCtD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0114	0.0285	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0113	0.0282	CbGpPWpGaD
Mecamylamine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0188	CcSEcCtD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0104	0.026	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0101	0.0252	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0101	0.0251	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00929	0.0232	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00928	0.0232	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0092	0.023	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00858	0.0214	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00858	0.0214	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00858	0.0214	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00856	0.0214	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00848	0.0212	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00827	0.0207	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00821	0.0205	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00783	0.0196	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00757	0.0189	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00756	0.0189	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00756	0.0189	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00711	0.0178	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00703	0.0176	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00703	0.0176	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00699	0.0175	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00692	0.0173	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00675	0.0169	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00656	0.0164	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0065	0.0162	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00643	0.0161	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00643	0.0161	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00634	0.0158	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00627	0.0157	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00617	0.0154	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.006	0.015	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0058	0.0145	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00579	0.0145	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00579	0.0145	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00574	0.0143	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00574	0.0143	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00573	0.0143	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00539	0.0135	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00539	0.0135	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00535	0.0134	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0053	0.0132	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00517	0.0129	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00511	0.0128	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00493	0.0123	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00493	0.0123	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0048	0.012	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00473	0.0118	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00444	0.0111	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0044	0.011	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0044	0.011	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00439	0.011	CbGpPWpGaD
Mecamylamine—CHRNB4—nervous system—amyotrophic lateral sclerosis	0.00401	0.141	CbGeAlD
Mecamylamine—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00392	0.00979	CbGpPWpGaD
Mecamylamine—CHRNB4—central nervous system—amyotrophic lateral sclerosis	0.00386	0.136	CbGeAlD
Mecamylamine—CHRNB4—brain—amyotrophic lateral sclerosis	0.00306	0.108	CbGeAlD
Mecamylamine—CHRNA3—nervous system—amyotrophic lateral sclerosis	0.00246	0.0868	CbGeAlD
Mecamylamine—CHRNA3—central nervous system—amyotrophic lateral sclerosis	0.00237	0.0835	CbGeAlD
Mecamylamine—CHRNA3—cerebellum—amyotrophic lateral sclerosis	0.00231	0.0816	CbGeAlD
Mecamylamine—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.00228	0.0806	CbGeAlD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00222	0.00554	CbGpPWpGaD
Mecamylamine—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.0022	0.0776	CbGeAlD
Mecamylamine—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.00215	0.0759	CbGeAlD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00188	0.0047	CbGpPWpGaD
Mecamylamine—CHRNA3—brain—amyotrophic lateral sclerosis	0.00188	0.0663	CbGeAlD
Mecamylamine—CHRNA2—brain—amyotrophic lateral sclerosis	0.00175	0.0616	CbGeAlD
